Latest NewsNewsTFT News

WHO approves Johnson and Johnson’s single-dose COVID-19 vaccine for emergency use

The World Health Organization (WHO) has officially approved the emergency use of the Johnson and Johnson’s (J&J) single-dose COVID-19 vaccine manufactured by J&J’s very own pharmaceutical company, Jannsen.

J&J’s COVID-19 vaccine is the third to receive support from the global health advisory body after Pfizer-BioNTech and Astrazeneca.

RELATED STORY: US regulators say Johnson & Johnson’s one dose COVID-19 vaccine offers ‘strong protection’ 

It is also the world’s first single-dose vaccine to receive emergency approval from WHO.

“Every new, safe and effective tool against COVID-19 is another step closer to controlling the pandemic,” said WHO Director-General Tedros Adhanom Ghebreyesus.

READ ON: U.S. rolls out 4 million single-dose Johnson and Johnson’s COVID-19 vaccines

He furthered that the vaccine would now be part of WHO’s COVAX facility, with an agreement to procure at least 500 million doses of J&J’s single-dose vaccine

COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi and WHO and is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to at least 20% of the population of both higher-income and lower-income countries.

Staff Report

The Filipino Times is the chronicler of stories for, of and by Filipinos all over the world, reaching more than 236 countries in readership. Any interesting story to share? Email us at [email protected]

Related Articles

Back to top button